Nymox Pharm Corp (NYMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NYMX | AMGN | GILD | VRTX | BIIB |
| Company | Nymox Pharm Corp | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2200 | 337.03 | 84.39 | 477.70 | 200.57 |
| High | 0.2200 | 338.70 | 84.65 | 482.86 | 204.18 |
| Low | 0.1827 | 334.61 | 83.57 | 476.27 | 200.11 |
| Last | 0.2000 | 337.85 | 84.54 | 483.43 | 203.24 |
| Change | -0.0490 | +4.93 | +0.65 | +9.27 | +5.65 |
| % Change | -19.68% | +1.48% | +0.77% | +1.96% | +2.86% |
| Volume | 932,700 | 644,444 | 3,658,862 | 381,634 | 524,864 |
| 20-Day Average Volume | 309,280 | 1,710,155 | 6,431,765 | 958,540 | 797,132 |
| Previous Close | 0.2490 | 332.92 | 83.89 | 474.16 | 197.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3282 | 329.64 | 80.11 | 480.05 | 201.73 |
| 20-Day Raw Stochastic | 12.57% | 90.60% | 97.17% | 52.70% | 80.67% |
| 20-Day Relative Strength | 33.51% | 58.53% | 73.21% | 51.20% | 48.40% |
| Weighted Alpha | -62.47 | +27.70 | +19.64 | +34.95 | -20.28 |
| Today's Opinion | 56% Sell | 96% Buy | 88% Buy | 56% Buy | 88% Sell |
| Previous Opinion | 56% Sell | 88% Buy | 88% Buy | 40% Buy | 100% Sell |
| Last Month's Opinion | 32% Buy | 88% Buy | 56% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -28.98% since 06/28/23 | +2.14% since 09/12/24 | +1.76% since 09/12/24 | +0.60% since 09/12/24 | +3.06% since 09/12/24 |
| Low | 0.1688 on 06/30/23 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 | 192.25 on 09/13/24 |
| High | 0.3500 on 07/03/23 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | -50.94% since 06/06/23 | +2.79% since 08/19/24 | +13.66% since 08/19/24 | -1.33% since 08/19/24 | -1.02% since 08/19/24 |
| Low | 0.1688 on 06/30/23 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 0.4170 on 06/16/23 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | -43.80% since 04/06/23 | +10.17% since 06/18/24 | +34.00% since 06/18/24 | +3.05% since 06/18/24 | -8.81% since 06/18/24 |
| Low | 0.1688 on 06/30/23 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 0.4950 on 05/08/23 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -50.73% since 01/06/23 | +24.06% since 03/19/24 | +15.27% since 03/19/24 | +15.98% since 03/19/24 | -6.71% since 03/19/24 |
| Low | 0.1688 on 06/30/23 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.5299 on 02/16/23 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,103 | 178,589,936 | 104,514,608 | 122,358,416 | 28,768,510 |
| Shares Outstanding, K | 90,515 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -6,580,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | -1,390,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 0.64 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 05/12/23 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 08/21/23 | 10/29/24 | 11/05/24 | 11/04/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 0.00 | 12.19 |